Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Blood and Marrow Transplantation (BMT)”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT00899847
What this trial is testing

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Who this might be right for
Transplantation, HomologousTransplantation, AutologousMultiple Myeloma+1 more
Stanford University 9
Not applicableStudy completedNCT00186576
What this trial is testing

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersBlood and Marrow Transplant (BMT)+2 more
Stanford University 40
Not applicableNot Yet RecruitingNCT07227155
What this trial is testing

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

Who this might be right for
Aplastic AnemiasHemoglobinopathiesBone Marrow Failure
Medical College of Wisconsin 375
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Large-scale testing (Phase 3)UnknownNCT00998270
What this trial is testing

Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Tehran University of Medical Sciences 185
Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Not applicableNot Yet RecruitingNCT07289087
What this trial is testing

Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy

Who this might be right for
Quality of LifePatient Reported Outcome (PRO)Allogeneic Blood and Marrow Transplantation (BMT)+1 more
Associazione Qol-one 162
Large-scale testing (Phase 3)Study completedNCT00824993
What this trial is testing

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 78
Not applicableStudy completedNCT00281814
What this trial is testing

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 36
Testing effectiveness (Phase 2)Study completedNCT00186394
What this trial is testing

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinBlood and Marrow Transplant (BMT)Lymphomas: Non-Hodgkin
Stanford University 35
Testing effectiveness (Phase 2)Study completedNCT01487577
What this trial is testing

Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

Who this might be right for
Allogeneic Blood and Marrow Transplantation (BMT)Graft Versus Host Disease
University of Pittsburgh 19
Large-scale testing (Phase 3)Study completedNCT03959241
What this trial is testing

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Who this might be right for
Acute LeukemiaChronic Myelogenous Leukemia (CML)Myelodysplasia+1 more
Medical College of Wisconsin 431
Very early researchStudy completedNCT01174940
What this trial is testing

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Who this might be right for
Stem Cell Leukemia of Unclear LineageGraft Versus Host Disease
University of Kansas Medical Center 22
Large-scale testing (Phase 3)Study completedNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Not applicableStudy completedNCT00507260
What this trial is testing

Nutritional Assessment Intervention to Improve Cancer-Related Fatigue

Who this might be right for
LeukemiaLymphomaFatigue
M.D. Anderson Cancer Center 10
Early research (Phase 1)Study completedNCT00185757
What this trial is testing

Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Multiple MyelomaBlood and Marrow Transplant (BMT)
Stanford University 21
Testing effectiveness (Phase 2)Ended earlyNCT00167180
What this trial is testing

Post Transplant Donor Lymphocyte Infusion

Who this might be right for
Leukemia, Myeloid, ChronicLymphomasMultiple Myeloma+4 more
Masonic Cancer Center, University of Minnesota 57
Not applicableStudy completedNCT00186342
What this trial is testing

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Who this might be right for
Acute DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+4 more
Stanford University 120
Testing effectiveness (Phase 2)Study completedNCT00809276
What this trial is testing

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Who this might be right for
LymphomaMultiple MyelomaLeukemia+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Load More Results